Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ensysce Biosciences Inc ENSC

Alternate Symbol(s):  ENSCW

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. Its pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection (TAAP) platform, and an over-dose protection opioid prodrug technology... see more

Recent & Breaking News (NDAQ:ENSC)

Ensysce Biosciences' Covistat Subsidiary "At Home Coronavirus Pill" Commencing to Phase 2 clinical development

GlobeNewswire May 7, 2021

Ensysce Biosciences Receives Investigational New Drug Allowance for its Unique PF614-MPAR(TM) Opioid with Overdose Protection

GlobeNewswire April 29, 2021

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of Mergers

GlobeNewswire March 16, 2021

SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

PR Newswire March 15, 2021

MERGER ALERT - LACQ, and COHR: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies

ACCESS Newswire February 25, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds LACQ, GWPH, PRSP, and CMD Shareholders About Its Ongoing Investigations

PR Newswire February 24, 2021

Ensysce Biosciences, Inc. And Leisure Acquisition Corp. Announce Appointment Of Dave Humphrey As Chief Financial Officer

PR Newswire February 18, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds EGOV, GRNV, LACQ, and GWPH Shareholders About Its Ongoing Investigations

PR Newswire February 17, 2021

MERGER ALERT - LACQ, COHR, and CLA: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies

ACCESS Newswire February 17, 2021

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Leisure Acquisition Corp. - LACQ

PR Newswire February 12, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Leisure Acquisition Corp. with Ensysce Biosciences, Inc.

Newsfile February 12, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds LACQ, VCVC, GWPH, and PRSP Shareholders About Its Ongoing Investigations

PR Newswire February 10, 2021

Moore Kuehn Encourages CRHM, GIX, LACQ, and GLUU Investors to Contact Law Firm

PR Newswire February 9, 2021

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Leisure Acquisition Corp. Merger

GlobeNewswire February 4, 2021

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Leisure Acquisition Corp. (Nasdaq - LACQ)

ACCESSWIRE IA February 3, 2021

SHAREHOLDER ALERT: WeissLaw LLP Investigates Leisure Acquisition Corp.

PR Newswire February 3, 2021

Ensysce Biosciences, Inc. And Leisure Acquisition Corp. To Host Investor Call Regarding Business Combination On February 3, 2021

PR Newswire February 2, 2021

Leisure Acquisition Corp. Enters Into Merger Agreement For Business Combination With Ensysce Biosciences, Inc.

PR Newswire February 1, 2021

Gateway Casinos & Entertainment Limited and Leisure Acquisition Corp. to Host Investor Call Regarding Business Combination on January 7, 2020

Canada NewsWire January 6, 2020

Gateway Casinos & Entertainment Limited and Leisure Acquisition Corp. to Combine in Transaction Valued at US$1.1 Billion (C$1.5 Billion)

Canada NewsWire December 27, 2019